Skip to main content
Clinical Trials/JPRN-jRCTs051220195
JPRN-jRCTs051220195
Recruiting
未知

Efficacy and Safety of the single oral dose method of the sodium picosulfate plus magnesium citrate for the preparation in colonoscopy

Kodama Yuzo0 sites145 target enrollmentMarch 17, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kodama Yuzo
Enrollment
145
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 17, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kodama Yuzo

Eligibility Criteria

Inclusion Criteria

  • 1\. patients undergoing colonoscopy
  • 2\. age 18 years or older at the time of informed consent
  • 3\. pssible to take laxatives
  • 4\. possible to give written consent on his/her own

Exclusion Criteria

  • 1\. patients with severe renal dysfunction (eGFR\< 30 mL/ min/ 1\.73m2\)
  • 2\. patients with severe heart failure (NYHA class III or IV)
  • 3\. patients with hyponaemia (\<136 mEq/L) or hypokalaemia (\<3\.5 mEq/L)
  • 4\. Patients with previous surgical resection of the colon or rectum (except for appendectomy and small bowel resection)
  • 5\. patients with suspected intestinal obstruction or perforation
  • 6\. patients with suspected hemorrhagic lesions such as hemorrhage
  • 7\. Patients with suspected or pre\-existing inflammatory bowel disease
  • 8\. pregnant women and patients who may be pregnant or lactating women
  • 9\. patients who have participated in another interventional study within 4 months
  • 10\. other patients deemed inappropriate by the investigators of this clinical study.

Outcomes

Primary Outcomes

Not specified

Similar Trials